<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>CALCIUM GLUCONATE- calcium gluconate injection, solution </strong><br>APP Pharmaceuticals, LLC<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>Calcium Gluconate Injection USP</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="b9423dac-8016-484f-b03d-de49cca093c6"></a><a name="section-1"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold"><span class="Emphasis">10%</span></span></p>
<p>0.465 Elemental Calcium (Ca<span class="Sup">++</span>) mEq/mL</p>
<p>0.68 mOsmol/mL 680 mOsmol/L</p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="f13b780c-5d4a-4237-87af-1a2cd5357edf"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Calcium Gluconate Injection, USP is a sterile, nonpyrogenic, supersaturated solution of calcium gluconate for intravenous use only. </p>
<p>Each mL contains:  Calcium gluconate 94 mg; calcium saccharate (tetrahydrate) 4.5 mg; Water for Injection q.s.  Hydrochloric acid and/or sodium hydroxide may have been added for pH adjustment (6.0-8.2). </p>
<p>Calcium saccharate provides 6% of the total calcium and stabilizes the supersaturated solution of calcium gluconate. </p>
<p>Each 10 mL of the injection provides 93 mg elemental calcium (Ca<span class="Sup">++</span>) equivalent to 1 g of calcium gluconate.  </p>
<p>The structural formula is:</p>
<div class="Figure"><img alt="structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c069b9bf-a17f-4727-9eb3-a6c69af883f8&amp;name=calcium-gluconate-injection-usp-figure-1-calcium-gluconate-structure.jpg"></div>
<br>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="afd0947a-9a6b-4869-9a3b-7d997daa6611"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Calcium is the fifth most abundant element in the body and is essential for maintenance of the functional integrity of nervous, muscular and skeletal systems, cell membranes and <span class="product-label-link" type="condition" conceptid="4023793" conceptname="Capillary permeability">capillary permeability</span>.  It is also an important activator in many enzymatic reactions and is essential to a number of physiologic processes including transmission of nerve impulses; contraction of cardiac, smooth and skeletal muscles; renal function; respiration; and blood coagulation.  Calcium also plays regulatory roles in the release and storage of neurotransmitters and hormones; in the uptake and binding of amino acids; in cyanocobalamin (vitamin B<span class="Sub">12</span>) absorption; and gastrin secretion.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="b3023221-adb0-4d55-85f6-e7bd53a75616"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Calcium Gluconate Injection, USP is used to treat conditions arising from calcium deficiencies such as <span class="product-label-link" type="condition" conceptid="380534" conceptname="Tetany">hypocalcemic tetany</span>, <span class="product-label-link" type="condition" conceptid="435510" conceptname="Hypocalcemia">hypocalcemia</span> related to <span class="product-label-link" type="condition" conceptid="140362" conceptname="Hypoparathyroidism">hypoparathyroidism</span> and <span class="product-label-link" type="condition" conceptid="435510" conceptname="Hypocalcemia">hypocalcemia</span> due to rapid growth or pregnancy.  It is also used in the treatment of black widow spider bites to relieve muscle cramping and as an adjunct in the treatment of <span class="product-label-link" type="condition" conceptid="4189941" conceptname="Rickets">rickets</span>, <span class="product-label-link" type="condition" conceptid="432594" conceptname="Osteomalacia">osteomalacia</span>, lead <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">colic</span> and magnesium sulfate overdosage.  Calcium gluconate has also been employed to decrease <span class="product-label-link" type="condition" conceptid="4023793" conceptname="Capillary permeability">capillary permeability</span> in allergic conditions, nonthrombocytopenic <span class="product-label-link" type="condition" conceptid="4047773" conceptname="Purpura">purpura</span> and exudative dermatoses such as <span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">dermatitis</span> herpetiformis and for <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span> of <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">eruptions</span> caused by certain drugs.  In <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span>, calcium gluconate may aid in antagonizing the cardiac toxicity, provided the patient is not receiving digitalis therapy.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="baf99c06-c834-4c23-a263-28e1b33429d9"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Calcium salts are contraindicated in patients with <span class="product-label-link" type="condition" conceptid="437894" conceptname="Ventricular fibrillation">ventricular fibrillation</span> or <span class="product-label-link" type="condition" conceptid="435511" conceptname="Hypercalcemia">hypercalcemia</span>.  Intravenous administration of calcium is contraindicated when serum calcium levels are above normal.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="fce710d6-b881-4ec4-972c-55f8ec595804"></a><a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First"><span class="Bold"><span class="Emphasis">For intravenous use only.  </span></span>Subcutaneous or intramuscular injection may cause severe <span class="product-label-link" type="condition" conceptid="4280654" conceptname="Necrosis">necrosis</span> and <span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">sloughing</span>.</p>
<p>WARNING: This product contains aluminum that may be toxic.  Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired.  Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum.</p>
<p>Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity.  Tissue loading may occur at even lower rates of administration.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="ed3d7b37-7968-4647-9fd2-254d356db903"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="42232-9">
<a name="a4e1f997-eb9e-48ce-8928-e5bae613d774"></a><a name="section-7.1"></a><p></p>
<h2>General</h2>
<p class="First">To avoid undesirable reactions that may follow rapid intravenous administration of calcium gluconate, the drug should be given slowly, e.g., approximately 1.5 mL over a period of one minute.  When injected intravenously, calcium gluconate should be injected through a small needle into a large vein in order to avoid too rapid an increase in serum calcium and <span class="product-label-link" type="condition" conceptid="4295895" conceptname="Extravasation">extravasation</span> of calcium solution into the surrounding tissue with resultant <span class="product-label-link" type="condition" conceptid="4280654" conceptname="Necrosis">necrosis</span>. </p>
<p>Rapid injection of calcium gluconate may cause vasodilation, decreased blood pressure, <span class="product-label-link" type="condition" conceptid="4169095" conceptname="Bradycardia">bradycardia</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac arrhythmias</span>, <span class="product-label-link" type="condition" conceptid="135360" conceptname="Syncope">syncope</span> and <span class="product-label-link" type="condition" conceptid="321042" conceptname="Cardiac arrest">cardiac arrest</span>. </p>
<p>Because of the danger involved in simultaneous use of calcium salts and drugs of the digitalis group, a digitalized patient should not receive an intravenous injection of a calcium compound unless indications are clearly defined.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="c0b5b6e2-5443-45a2-a612-4c470fc846b0"></a><a name="section-7.2"></a><p></p>
<h2>Drug Interactions<br>
</h2>
<p class="First">The inotropic and toxic effects of cardiac glycosides and calcium are synergistic, and <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">arrhythmias</span> may occur if these drugs are given together (particularly when calcium is given intravenously).  Intravenous administration of calcium should be avoided in patients receiving cardiac glycosides; if necessary, calcium should be given slowly in small amounts.  </p>
<p>Calcium complexes tetracycline antibiotics rendering them inactive.  The two drugs should not be given at the same time orally nor should they be mixed for parenteral administration.  </p>
<p>Calcium gluconate injection has been reported to be incompatible with intravenous solutions containing various drugs.  Published data are too varied and/or limited to permit generalizations, and specialized reference should be consulted for specific information.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="c75db13c-2c8c-4fab-8df1-f76412a5d154"></a><a name="section-7.3"></a><p></p>
<h2>Drug/Laboratory Test Interactions<br>
</h2>
<p class="First">Transient elevations of plasma 11-hydroxycorticosteroid levels (Glenn-Nelson technique) may occur when intravenous calcium is administered but levels return to control values after one hour.  In addition, intravenous calcium gluconate can produce false-negative values for serum and urinary magnesium.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="cfd83468-a028-403c-8257-b256b59428ea"></a><a name="section-7.4"></a><p></p>
<h2>Pregnancy</h2>
<p class="First"><span class="Italics"><span class="Emphasis">Teratogenic Effects: Pregnancy Category C</span></span>— </p>
<p>Animal reproduction studies have not been conducted with calcium gluconate.  It is also not known whether calcium gluconate can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.  Calcium gluconate should be given to a pregnant woman only if clearly needed.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="f5730f9d-d5de-48dc-b81b-d2ac14f3f241"></a><a name="section-7.5"></a><p></p>
<h2>Nursing Mothers<br>
</h2>
<p class="First">It is not known whether this drug is excreted in human milk.  Because many drugs are excreted in human milk, caution should be exercised when calcium gluconate is administered to a nursing woman.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="f165f32e-a9b4-49f0-9a89-c379604ac1ba"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Patients may complain of <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">tingling sensations</span>, a <span class="product-label-link" type="condition" conceptid="4252540" conceptname="Sense of oppression">sense of oppression</span> or heat waves and a calcium or chalky taste following the intravenous administration of calcium gluconate.  </p>
<p>Rapid intravenous injection of calcium salts may cause vasodilation, decreased blood pressure, <span class="product-label-link" type="condition" conceptid="4169095" conceptname="Bradycardia">bradycardia</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac arrhythmias</span>, <span class="product-label-link" type="condition" conceptid="135360" conceptname="Syncope">syncope</span> and <span class="product-label-link" type="condition" conceptid="321042" conceptname="Cardiac arrest">cardiac arrest</span>.  Use in digitalized patients may precipitate <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">arrhythmias</span>. </p>
<p>Local <span class="product-label-link" type="condition" conceptid="4280654" conceptname="Necrosis">necrosis</span> and <span class="product-label-link" type="condition" conceptid="444202" conceptname="Abscess">abscess</span> formation may occur with intramuscular injection.</p>
<br>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="cf85a7f4-7d58-4734-b8cd-ce4438af014f"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">The dose is dependent on the requirements of the individual patient.  Intravenous calcium gluconate injection must be administered slowly.</p>
<div class="Section" data-sectionCode="34068-7">
<a name="af316246-55c5-4c6a-a51e-493de3821ebb"></a><a name="section-9.1"></a><p></p>
<h2>Usual Dosage<br>
</h2>
<p class="First"><span class="Italics"><span class="Emphasis">Adults</span></span>—500 mg to 2 g (5 to 20 mL)</p>
<p><span class="Italics"><span class="Emphasis">Pediatric patients</span></span>—200 to 500 mg (2 to 5 mL)</p>
<p><span class="Italics"><span class="Emphasis">Infants</span></span>—Not more than 200 mg (not more than 2 mL) </p>
<p> </p>
<p>Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.</p>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="b702f2ba-893c-491a-9144-7afff1bdbd39"></a><a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<table><tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Bold"><span class="Emphasis">Product</span></span></p>
<p><span class="Bold"><span class="Emphasis">No.</span></span></p>
</td>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Bold"><span class="Emphasis">NDC </span></span></p>
<p><span class="Bold"><span class="Emphasis">No.</span></span></p>
</td>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Bold"><span class="Emphasis">Calcium Ion</span></span></p>
<p><span class="Bold"><span class="Emphasis">(mEq/mL)</span></span></p>
</td>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Bold"><span class="Emphasis">Volume/</span></span></p>
<p><span class="Bold"><span class="Emphasis">Vial Size</span></span></p>
<p><span class="Bold"><span class="Emphasis">(mL)</span></span></p>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">31110</p></td>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">63323-311-10</p></td>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">0.465</p></td>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">10</p></td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">31150</p></td>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">63323-311-50</p></td>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">0.465</p></td>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">50</p></td>
</tr>
</tbody></table>
<p class="First">Packaged in 25 vials per tray. </p>
<p>Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].  Do not permit to freeze.</p>
<p><span class="Bold"><span class="Emphasis">Preservative Free.  </span></span>Discard unused portion.Use only if solution is clear and seal intact.</p>
<p>Vial stoppers do not contain natural rubber latex.</p>
<p><span class="Bold"><span class="Emphasis">NOTE: Supersaturated solutions are prone to precipitation.  The precipitate, if present, may be dissolved by warming the vial to 60° to 80°C, with occasional <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">agitation</span>, until the solution becomes clear. Shake vigorously.  Allow to cool to room temperature before dispensing.  Use injection only if clear immediately prior to use.</span></span></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="fd18af97-2d4b-46ef-841d-a74ead847a84"></a><a name="section-11"></a><p></p>
<h1></h1>
<p class="First"><img alt="logo" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c069b9bf-a17f-4727-9eb3-a6c69af883f8&amp;name=calcium-gluconate-injection-usp-figure-2-add_band_logo.jpg"> </p>
<p>45805F</p>
<p>Revised: February 2009</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="cff66284-432e-4030-91cb-25546cbc55b7"></a><a name="section-12"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold"><span class="Emphasis">PACKAGE LABEL - PRINCIPAL DISPLAY - Calcium Gluconate 50 mL Single Dose Vial Label</span></span></p>
<p><span class="Bold"><span class="Emphasis">NDC </span></span>63323-311-50</p>
<p>31150</p>
<p><span class="Bold"><span class="Emphasis">Calcium Gluconate Injection, USP</span></span> </p>
<p><span class="Bold"><span class="Emphasis">10%  (100 mg/mL)</span></span></p>
<p>For Direct Slow IV or IV Additive Use Only</p>
<p><span class="Bold"><span class="Emphasis">50 mL</span></span> Single Dose Vial</p>
<p>Rx only</p>
<p> </p>
<div class="Figure"><img alt="31150-vial" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c069b9bf-a17f-4727-9eb3-a6c69af883f8&amp;name=calcium-gluconate-injection-usp-figure-3-31150-vial.jpg"></div>
<br><br>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>CALCIUM GLUCONATE 		
					</strong><br><span class="contentTableReg">calcium gluconate injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:63323-311</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>CALCIUM GLUCONATE</strong> (CALCIUM CATION) </td>
<td class="formItem">CALCIUM GLUCONATE</td>
<td class="formItem">94 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>HYDROCHLORIC ACID</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM HYDROXIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CALCIUM SACCHARATE</strong></td>
<td class="formItem">4.5 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:63323-311-10</td>
<td class="formItem">25  in 1 TRAY</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">10 mL in 1 VIAL, SINGLE-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:63323-311-50</td>
<td class="formItem">25  in 1 TRAY</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem"></td>
<td class="formItem">50 mL in 1 VIAL, SINGLE-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">08/09/2000</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>APP Pharmaceuticals, LLC
							(608775388)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">APP Pharmaceuticals, LLC</td>
<td class="formItem"></td>
<td class="formItem">840771732</td>
<td class="formItem">MANUFACTURE</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 1/2012<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>d166384d-8b2d-4d12-9488-3690273de0d4</div>
<div>Set id: c069b9bf-a17f-4727-9eb3-a6c69af883f8</div>
<div>Version: 1</div>
<div>Effective Time: 20120124</div>
</div>
</div> <div class="DistributorName">APP Pharmaceuticals, LLC</div></p>
</body></html>
